Jump to Main Content

Programs

Special Interest Sessions

ASH Advances COVID Research 2021

Speakers:

Lisa Baumann Kreuziger, MD
Versiti Blood Center of Wisconsin
Menomonee Falls, WI
Thrombosis in the Setting of COVID-19

Wendy Cozen, DO,MPH
USC Norris Comprehensive Cancer Center
Manhattan Beach, CA
Outcomes of COVID-19 Infection in Hematology Patients

Jeffery Auletta, MD
Nationwide Children's Hospital
Columbus, OH
Immunology and Immune Response in COVID-19 Vaccines

back to top

ASH Choosing Wisely® Campaign: 2021 ASH Choosing Wisely Champions

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Chair:

Ming Y Yeong Lim, MA,MBBChir
University of Utah
Salt Lake City, UT

Speakers:

Thomas Bodley, MD
Sunnybrook Health Sciences Center
Toronto, ON, Canada
Reducing Repetitive Diagnostic Phlebotomy in an Intensive Care Unit: A Quality Improvement Project

Srila Gopal
University of California San Diego
La Jolla, CA
Establishing Same Day Infusion Treatment Protocols for Uncomplicated Sickle Cell Vaso-Occlusive Crises Utilizing a Telemedicine Platform

Matthew Tenison McEvoy, MD, BA
Texas Children's Hospital
Houston, TX
Practice Standard for Management of Nutritional Iron Deficiency Anemia in the Emergency Department: A Quality Improvement

back to top

ASH Foundation Run/Walk

back to top

ASH Practice Partnership Lunch Program

Chair:

Chancellor E Donald, MD
71236
chancellordonald@hotmail.com, New Orleans, LA

Speakers:

Michael D Tarantino, MD
Bleeding and Clotting Disorders Insitute
Peoria, IL
Opportunities for Practices to Expand Telehealth Services and Focus on Recruitment and Retention Efforts

Christopher R. Flowers
MD Anderson Cancer Center
Houston, TX
Lessons Learned on Disparities and Developing New Delivery Points of Care

Jennifer Green, MD
Vanderbilt University Medical Center
Nashville, TN
Exploring the Changing Methods of Training Fellows and Residents and the Use of CME for Hematologists in Practice

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs: Treatment Advances in Rare Diseases

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs: Treatment Landscape in the Era of Novel Therapies

back to top

Blood and Beyond

back to top

Gene Editing and Real-World Data: A New Generation for Real-World Evidence

Chair:

William A. Wood, MD, MPH
University of North Carolina
Chapel Hill, NC

back to top

Grassroots Network Lunch

A Discussion with Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention

The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. The keynote speaker for this year's Grassroots Network Lunch will be Rochelle Walensky, MD, MPH, the Director of the Centers for Disease Control and Prevention. Dr. Walensky will discuss efforts by the CDC to both highlight and address health disparities and racism as a threat to the nation's health as well as the important role hematologists can play in furthering this goal.

Chair:

Jennifer Holter Chakrabarty, MD
University of Oklahoma
Oklahoma City, OK

Speaker:

Rochelle Walensky, MD, MPH
Centers For Disease Control and Prevention
Atlanta, GA
CDC's Efforts to Address Health Disparity as a Threat to the Nation's Health

back to top

Health Equity Rounds

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. 

Health Equity Rounds Goals and Objectives:

  1. Create a longitudinal, bi-directional clinical case-based series to encourage providers to recognize and explore the impact of implicit bias and systemic racism on patients with hematologic conditions
  2. To inspire participants to engage at the individual, community, and institutional level to address and mitigate bias and systemic racism
  3. To provide solutions/tools to enhance providers’ confidence in their abilities to decrease the impact of implicit bias at the individual, community, and institutional levels

The pilot series will kick-off with a 60-minute in-person session at the 2021 ASH Annual Meeting. Following the meeting, a series of bi-monthly webinars will be conducted focusing on various disease cases and provocative health equity topics. The series will include interactive and engaging techniques through experiential learning, breakout sessions, and interactive lectures. The pilot series will conclude with an in-person meeting at the 2022 ASH Annual Meeting.

back to top

How to Get Published in a Peer-Reviewed Journal

back to top

How to Peer Review a Scientific Paper

back to top

Medical Educators Symposium

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with a general session focused on medical education principles.

Speakers:

Ariela L. Marshall, MD
Mayo Clinic
Rochester, MN
Tips for Effective Feedback for Millennials

Leslie Renee Ellis, MD, MSHPEd
Wake Forest Baptist Health Comprehensive Cancer Center
Winston-Salem, NC
Brunout

Teresa Scordino
University of Oklahoma
Oklahoma City, OK
Mei Participant Project Highlight on Technology and Medical Education

Leslie Segal Kersun
Children's Hospital of Philadelphia
Philadelphia, PA
Breakout #1: How to Develop Effective Small Group Teaching Sessions

Martina C Murphy, MD
UF Hematology/Oncology
Gainesville, FL
Breakout #1: How to Develop Effective Small Group Teaching Sessions

Aaron T. Gerds, MD,MS
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH
Breakout #2: Use of Twitter in Hematology

Marc J. Kahn
Tulane University
Las Vegas, NV
Breakout #3: How to be a Good Mentor

Ted Wun, MD
University of California Davis School of Medicine
Sacramento, CA
Breakout #3: How to be a Good Mentor

back to top

Meet the Blood Editors (for in-person participants)

These sessions provide the opportunity for attendees to meet with the associate editors of Blood and discuss recent changes to the journal as well as submission and peer-review processes and policies, with each session giving a unique focus. Seating is limited and available on a first-come, first-served basis.

back to top

Meet the Blood Editors (for in-person participants)

These sessions provide the opportunity for attendees to meet with the associate editors of Blood and discuss recent changes to the journal as well as submission and peer-review processes and policies, with each session giving a unique focus. Seating is limited and available on a first-come, first-served basis.

back to top

MRI Career Development Luncheon

ASH Opportunities, Navigating the Pathway

Moderators:

Ruben A. Mesa, MD, FACP
UT Health San Antonio Cancer Center
San Antonio, TX

Oreofe O. Odejide, MD,MPH
Dana-Farber Cancer Institute
Boston, MA

Panelists:

Staci D. Arnold, MD,MBA,MPH
Children's Healthcare of Atlanta/Emory University
Atlanta, GA

Esther A. Obeng, MD,PhD
St. Jude Children's Research Hospital
Memphis, TN

Melody Smith, MD, MS
Memorial Sloan-Kettering Cancer Center
New York, NY

back to top

Promoting Minorities in Hematology Oral Presentations Room 1

back to top

Promoting Minorities in Hematology Oral Presentations Room 2

back to top

Promoting Minorities in Hematology Oral Presentations Room 3

back to top

Promoting Minorities in Hematology Reception

back to top

Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults

In 2017 ASH initiated its first guideline development effort on a malignant topic: acute myeloid leukemia in older adults. This topic was selected as clinically important and largely unaddressed by existing guidelines. Development of these guidelines, including systematic evidence review, was supported by the McMaster University GRADE Centre. The guidelines were published in Blood Advances on August 6, 2020.

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice. 

Chair:

Mikkael A. Sekeres, MD
Cleveland Clinic Taussig Cancer Institute
Miami, FL

Speakers:

Christopher S. Hourigan, MD
NHLBI
Bethesda, MD
Epidemiology and Clinical Risk Factors for AML Outcome in Older Adults

Jessica K. Altman, MD
Northwestern University Feinberg School of Medicine
Chicago, IL
Intensive Vs. Less-Intensive Induction Therapy (and in which category should we place venetoclax combinations?)

Pinkal Desai, MD,MPH
Weill Cornell Medical College
New York, NY
So You’Re in a Remission. Now What?

Thomas W. LeBlanc, MD,MA,MS
Duke university hospital
Hillsborough, NC
Supportive Care during Active Therapy and during Active Palliation

back to top

Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease

In 2016, ASH initiated the development of five clinical practice guidelines on sickle cell disease, addressing acute and chronic complications of the disease as well as stem cell transplantation. These first four guidelines, on cardiopulmonary and kidney Disease, transfusion support, cerebrovascular disease, and acute and chronic pain have been published in Blood Advances, with the remaining stem cell transplantation chapter scheduled for publication in 2021.

In this special session, speakers will highlight particularly notable recommendations from the SCD guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies. 

Chair:

Robert I. Liem, MD, MS
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL

Speakers:

Ifeyinwa (IFY) Osunkwo, MD, MPH
Sickle Cell Disease Enterprise at The Levine Cancer Institute/Atrium Health
Charlotte, NC
Dissemination and Implementation

Ted Wun, MD
University of California Davis School of Medicine
Sacramento, CA
Policy Shaping and Quality Metrics

John J. Strouse, MD, PhD
Duke University School of Medicine
Durham, NC
Patient Versions

back to top

Special Education Session on ASH Clinical Practice Guidelines on Venous Thromboembolism

Ten ASH clinical practice guidelines on VTE have been published in Blood Advances, and two others are planned for submission to Blood Advances in 2021 (thrombophilia testing and a special adaption of the VTE guidelines for Latin America).

In this special session, speakers will highlight particularly notable recommendations from the VTE guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies and on the rapid development of COVID-19 guidelines on anticoagulation.

Chair:

Adam Cuker, MD,MS
University of Pennsylvania
Philadelphia, PA

Speakers:

Kristen M. Sanfilippo, MD
Washington University in St. Louis School of Medicine
Chesterfield, MO
COVID-19 and VTE

Saskia Middeldorp, MD,PhD
Academic Medical Center
Nijmegen, Netherlands
Thrombophilia

Ignacio Neumann, MD,PhD
Pontificia Universidad Católica
Santiago, CHL
VTE in Latin America

back to top

Special Education Session on ASH Clinical Practice Guidelines on von Willebrand Disease

The American Society of Hematology collaborated with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and Kansas University Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease (VWD). These guidelines were published in January of 2021.

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice.

Co-Chairs:

Nathan T. Connell, MD
Brigham and Women's Hospital
Boston, MA

Veronica H Flood, MD
Medical College of Wisconsin
Milwaukee, WI

Paula D. James, MD,FRCPC
Queen's University
Kingston, ON, Canada

Speakers:

Michelle Lavin, MB, PhD, FRCPath
Royal College of Surgeons in Ireland
Dublin 2, Ireland
Management of VWD

Peter A. Kouides, MD
University of Rochester
Rochester, NY
Management of VWD

Robert F. Sidonio Jr., MD, MSc
Emory University
Atlanta, GA
Diagnosis of VWD

back to top

Special Education Session on Collaborative Hematology Networks

Speakers:

Charles S. Abrams, MD
University of Pennsylvania
Philadelphia, PA
The ASH Research Collaborative Sickle Cell Disease Clinical Trials Network

Ehab L. Atallah, MD
Medical College of Wisconsin
Milwaukee, WI
H Jean Khoury Cure CML Consortium

Lisa Baumann Kreuziger, MD
Versiti Blood Center of Wisconsin
Menomonee Falls, WI
Venous thromboEmbolism Network US (VENUS)

back to top

Special Education Session on Collaborative Hematology Networks - Live Q&A

Clinical research, especially randomized controlled trials (RCT), require collaboration. Advantages of multicenter clinical research are faster study completion and greater generalizability of results. Clinical research networks allow experts to conduct multiple studies around the same disease state. The session will explore three recently developed clinical trial networks focused on hematologic diseases.

Dr. Charles Abrams will discuss the ASH Research Collaborative Data Hub and Sickle Cell Disease Clinical Trials Network (SCD-CTN) which is composed of highly vetted & engaged clinical trial sites, a database of well characterized patients, and advisory boards for scientific and community review. Foundational to the SCD-CTN is community engagement. The SCD-CTN is uniquely positioned to accelerate development and approval of novel therapy to improve the quality of life for those living with sickle cell disease.

The H. Jean Khoury Cure CML Consortium (HJKC3) is named after the late Dr. H. Jean Khoury who had a vision to improve the care of patients with CML through collaboration. The HJKC3 is a group of researchers from 19 world-class academic medical centers throughout North America committed to curing CML through innovative research. In this talk, Dr. Ehab Atallah will discuss how the HJKC3 was established, current activities and future directions.

Dr. Baumann Kreuziger will discuss the Venous thromboembolism Network United States (VENUS), a research network composed of investigators from 38 states whose mission is to develop and conduct clinical trials and research about thrombosis. She will discuss the network development, lessons learned, and how COVID-19 affected the network.

Chair:

Lisa Baumann Kreuziger, MD
Versiti Blood Center of Wisconsin
Menomonee Falls, WI

back to top

Special Interest Session on Systems-Based Hematology

patient blood management

This session will again focus on the role, importance, and value of the systems based hematologist to the health care system. The focus of this years session will be on patient blood management (PBM). The first session will highlight the development and implementation of a pre-operative anemia clinic. The second session will focus on the development, implementation, as well as support needed in developing an overall PBM program. Both of these sessions will spotlight the role of the hematologist in the success of a PBM program.

Chair:

Marc Zumberg, MD
University of Florida
Gainesville, FL

Speakers:

Marc Zumberg, MD
University of Florida
Gainesville, FL
An Introduction to Systems-Based Hematology

Colleen Morton, MD
Vanderbilt
Nashville, TN
How I Set Up a Perioperative Blood Management and Preoperative Anemia Evaluation Program-Preoperative Phase

Bruce Spiess
University of Florida College of Medicine
Gainesville, FL
How I Set Up a Bloodless Medicine Program

back to top

Special Scientific Session on Race and Science

Speakers:

Gilda A. Barabino, PhD
Olin College of Engineering
Needham, MA
Implications of Racial Biases on Hematology Research and Study Design

Deirdra R Terrell, PhD
The University of Oklahoma Health Sciences Center
Oklahoma City, 
What Is Race-- a Genetic, Biological, or Social Construct?

back to top

Special Scientific Session on Race and Science - Live Q&A

Co-Chairs:

Lachelle D. Weeks, MD, PhD
Harvard Medical School, Dana Farber Cancer Institute
Brookline, MA

Wally R Smith, MD
Virginia Commonwealth University
Richmond, VA

back to top

Special Symposium on Quality: Identifying and Eliminating Inequity in the Provision of Healthcare

This year's Special Symposium on Quality will focus on examining how systemic inequities impact healthcare quality, and what hematologists can do to promote more equitable provision of healthcare.  The session will include practical examples of the negative impact of inequity on the quality of care patients receive, proven mechanisms for effectuating meaningful change in health equity and outcomes, and a keynote address on the social and moral determinants of health.  The session will conclude with Q&A and a call-to-action for attendees to pursue their own quality improvement projects that address issues related to equity and/or implicit bias.

Co-Chairs:

Amy Billett, MD
Nemours / Al duPont Hospital for Children
Wilmington, DE

Jacquelyn M. Powers, MD,MSc
Baylor College of Medicine
Houston, TX

Speakers:

Lanetta Bronte-Hall, MD, MPH, MSPH
Foundation for Sickle Cell Disease Research
Hollywood, FL
Mechanisms for Change in Health Equity

Maureen Achebe, MD, MPH
Hematology Division Brigham and Women's
Boston, MA
Equity in Patient Care and Outcomes

Kara Odom Walker, MD, MPH, MSHS
Nemours Children's Health
Washington, DC
The Social and Moral Determinants of Health / Equity in Healthcare

back to top

The Role of Real World Data Collection in Hematologic Malignancies

Chair:

Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center
New York, NY

back to top

Training Program Directors' Workshop

Mentorship?and Career Development

The Training Program Directors Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training to share lessons learned, best practices, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network. 

Speakers:

Alice Ma, MD
University of North Carolina At Chapel Hill
Chapel Hill, NC
Mentorship?and Career Development

Leslie Segal Kersun
Children's Hospital of Philadelphia
Philadelphia, PA
Mentorship?and Career Development

Michael Linenberger, MD
University of Washington
Seattle, WA
Well-Being and Resilience

Kenneth Adler, MD
Summit Medical Group, MD Anderson Cancer Center
Morristown, NJ
Well-Being and Resilience

Martha L. Arellano, MD
Emory University School of Medicine
Atlanta, GA
Recruitment and Retention

Rakhi P. Naik, MD
Johns Hopkins Hospital
Baltimore, MD
Recruitment and Retention